A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
PHASE3CompletedINTERVENTIONAL
Enrollment
650
Participants
Timeline
Start Date
April 30, 1995
Primary Completion Date
February 28, 1998
Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG
MK0217, alendronate sodium / Duration of Treatment : 2 Years
DRUG
Comparator : calcium carbonate /Duration of Treatment : 2 Years
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00398606 - A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) | Biotech Hunter | Biotech Hunter